Eligibility Criteria in Clinical Trials: The Complete Guide to Who Can Join a Study and Why

Every clinical trial begins with the same question: who should take part?
The answer is written into a document called the study protocol, in a section
known as the eligibility criteria.

These criteria explain exactly which characteristics a person must have—and
which characteristics they must not have—to enroll in a particular research study.

For anyone considering a clinical trial, eligibility criteria are often the
first hurdle and one of the biggest sources of confusion. Many people who express
interest in research are not enrolled, not because anything is wrong with them,
but because they do not match the specific participant profile required by that study.

This guide explains what eligibility criteria are, the difference between inclusion
and exclusion criteria, why researchers use them, who decides them, how the screening
process works, and what you can do if you do not qualify for a particular trial.

What Are Eligibility Criteria in Clinical Trials?

Eligibility criteria are the specific requirements a person must meet to participate
in a clinical trial. They are defined before the study begins, written into the research
protocol, reviewed by regulators and ethics boards, and applied consistently to every
potential volunteer.

Eligibility criteria commonly address factors such as:

• Age
• Sex and reproductive status
• The medical condition being studied
• The stage, severity, or duration of the condition
• Past and current treatments
• Current medications
• Other medical or psychiatric conditions
• Laboratory values and vital signs
• Lifestyle factors
• The ability to attend study visits and complete procedures

Together, these requirements draw a precise boundary around the study population.

There are two sides to every set of eligibility criteria:

• Inclusion criteria: the characteristics a person must have to join the study.
• Exclusion criteria: the characteristics that prevent a person from joining,
  even if they meet the inclusion criteria.
• 
  

A person is generally eligible only when they meet all applicable inclusion criteria
and none of the exclusion criteria.

Missing one inclusion requirement or meeting one exclusion condition may disqualify
someone from that particular trial. It does not mean the person is ineligible for all
clinical research.

It may help to think of eligibility criteria as the recipe for a valid scientific
experiment. Researchers need participants who are similar in the ways that matter to
the research question so that changes can be linked more confidently to the treatment
being studied rather than to unrelated differences among participants.

Inclusion Criteria vs. Exclusion Criteria: What Is the Difference?

Inclusion and exclusion criteria work together, but they serve different purposes.

Inclusion Criteria: Defining Who the Study Is For

Inclusion criteria describe the target population. These are the people the
investigational treatment is intended to help and the people in whom the study
question can be meaningfully answered.

Common inclusion criteria may include:

• A confirmed diagnosis of the condition being studied
• A diagnosis at a specific stage or severity
• A defined age range
• Specific laboratory values or test results
• A minimum amount of time since diagnosis
• A documented response or lack of response to previous treatments
• The ability to attend scheduled visits
• The ability to complete study procedures
• The ability to understand and sign informed consent

Every required inclusion criterion must generally be met. For example, if a trial
requires participants to be between 40 and 75 years old, someone who is 38 would not
qualify even if they match every other requirement.

Exclusion Criteria: Protecting Participants and the Data

Exclusion criteria identify people for whom participation could be unsafe or whose
circumstances could make the results difficult to interpret.

Common exclusion criteria may include:

• Other medical conditions that could be worsened by the investigational treatment
• Conditions that could interfere with the study results
• Current medications that may interact with the study treatment
• Pregnancy or breastfeeding
• Recent participation in another clinical trial
• Allergies to ingredients in the investigational medication
• Laboratory values outside a protocol-defined safe range
• Significant liver, kidney, heart, or other organ impairment

Exclusion criteria are not usually negotiable. Each one exists either to protect
participants from a known or suspected risk or to preserve the scientific integrity
of the study.

Being excluded is not a judgment about a person’s health, value, or willingness to help.
It simply means that a particular study is not considered a safe or scientifically
appropriate match.

Why Do Eligibility Criteria Exist?

Eligibility criteria serve three fundamental purposes. Understanding these purposes
can make the screening process feel less frustrating.

1. Participant Safety

The first responsibility of any research team is to protect the people taking part.
Many exclusion criteria exist because a treatment may create a specific risk for a
particular group.

For example:

• People with impaired kidney function may process a medication differently
• Certain prescription drugs may interact with an investigational compound
• A treatment that has not been studied in pregnancy may not be offered during pregnancy
• Some medical conditions may increase the chance of side effects

Eligibility criteria help ensure that people who may face an unacceptable level of risk
are not exposed to the investigational treatment.

2. Scientific Validity

Clinical trials are designed to answer a precise question: does a particular treatment
produce a particular effect in a defined population?

If participants differ widely in ways that influence the outcome, it becomes difficult
to tell whether the results were caused by the investigational treatment or by those
unrelated differences.

Examples of factors that may affect results include:

• Different disease stages
• Conflicting medications
• Major unrelated medical conditions
• Different levels of previous treatment exposure
• Uncontrolled lifestyle or behavioral factors

Enrolling participants with a defined set of shared characteristics helps produce
results that are more reliable and scientifically valid.

3. Relevance to Future Patients

Eligibility criteria also affect who the study results apply to.

When a clinical trial enrolls people who resemble the patients most likely to use the
treatment in real-world medical practice, doctors and regulators can better understand
how broadly the findings may apply.

This is one reason regulators have encouraged clinical trial sponsors to broaden
eligibility criteria when it can be done safely. The goal is to make trial populations
more representative of the patients who may eventually receive the treatment.

Who Decides the Eligibility Criteria for a Study?

Eligibility criteria are not created by the local research site that screens or enrolls
participants. They are established before the first volunteer enters the study.

The Sponsor and Study Designers

The organization funding and designing the clinical trial develops the protocol,
including the eligibility requirements.

The sponsor may be:

• A pharmaceutical company
• A biotechnology company
• A university
• A government agency
• A nonprofit research organization

The eligibility criteria are usually informed by earlier scientific evidence, including
laboratory research, animal studies, and previous phases of human testing.

Regulatory Agencies

In the United States, the Food and Drug Administration reviews many clinical trial
designs involving investigational drugs and medical devices.

Regulators may question criteria that appear unnecessarily narrow and may encourage
sponsors to include broader groups when safety and scientific validity allow.

Institutional Review Boards

Before a clinical trial can begin, an independent ethics committee called an
Institutional Review Board reviews the protocol.

The IRB evaluates whether:

• The study is ethical
• Risks have been minimized
• The informed consent process is appropriate
• Participant rights are protected
• Eligibility criteria are scientifically justified

Research Sites Apply the Criteria

Clinical research sites such as AIM Trials screen volunteers against the protocol
exactly as written.

Research coordinators and investigators can explain why a criterion exists, but they
cannot simply ignore or waive it for an individual participant.

Applying the criteria consistently means that participants at every site are evaluated
according to the same requirements.

Common Types of Eligibility Criteria

Although every protocol is different, most eligibility criteria fall into a group of
common categories.

Age

Nearly every clinical trial specifies an age range.

A study might enroll:

• Adults ages 18 to 65
• Adults age 50 and older
• Older adults age 65 and above
• Children within defined pediatric age groups

Age matters because the body may absorb, metabolize, and respond to treatments
differently across the lifespan.

Sex and Reproductive Status

Some studies enroll only one sex when the medical condition or treatment is
sex-specific.

Many protocols also include requirements related to pregnancy prevention, contraception,
pregnancy testing, breastfeeding, or reproductive status.

Diagnosis, Stage, and Severity

Most treatment studies require a confirmed diagnosis of the condition being investigated.

The protocol may also require a particular:

• Disease stage
• Symptom severity
• Length of illness
• Test result
• Rating scale score

Treatment History

Some trials seek participants who are newly diagnosed and have not yet received treatment.
Others specifically enroll people whose condition has not responded to standard therapy.

Protocols may ask about:

• Previous prescription medications
• Previous procedures or surgeries
• Past psychotherapy or behavioral treatment
• Response to previous treatments
• Recent participation in another trial

Current Medications

Certain medications can interact with an investigational treatment or make it difficult
to measure the study outcome.

A protocol may list medications that are permitted, prohibited, or allowed only at a
stable dose.

Some trials require a washout period, which is a defined period without a particular
medication before the study begins. Any medication change should be managed under
appropriate medical supervision.

Other Health Conditions

Medical or psychiatric conditions beyond the one being studied are called comorbidities.

Examples that may affect eligibility include:

• Uncontrolled high blood pressure
• Significant heart disease
• Impaired liver function
• Impaired kidney function
• Uncontrolled diabetes
• Active substance use disorders
• Other conditions that could interfere with study assessments

Laboratory Values and Vital Signs

Screening commonly includes blood work and vital signs.

Protocols may define acceptable ranges for:

• Blood counts
• Liver enzymes
• Kidney function
• Blood pressure
• Heart rate
• Electrolytes
• Pregnancy testing

Lifestyle and Logistics

Some studies include criteria related to smoking, alcohol use, recreational substances,
body mass index, diet, exercise, or other lifestyle factors.

Participants must also be able to attend visits and complete required study procedures
for the duration of the trial.

Healthy Volunteers

Not every clinical trial enrolls people with a medical condition.

Early-phase studies, pharmacology studies, and some vaccine studies may enroll healthy
volunteers. These studies have their own eligibility criteria, often focused on confirming
the absence of significant medical conditions.

How the Clinical Trial Screening Process Works

Meeting the eligibility criteria on paper is only the beginning. Every volunteer completes
a structured screening process before enrollment.

Step 1: Pre-Screening

Pre-screening is often completed by phone or through an online questionnaire.

It may review:

• Age
• Diagnosis
• Current medications
• Major medical history
• Previous treatments
• Location and availability

Pre-screening helps identify obvious mismatches before a volunteer travels to the research
site.

AIM Trials offers confidential pre-screening for currently enrolling research studies.

Step 2: Informed Consent

Before any study-specific screening procedure begins, the research team reviews the
informed consent document with the volunteer.

The document explains:

• The purpose of the trial
• The procedures involved
• The visit schedule
• Potential risks and discomforts
• Possible benefits
• Alternative treatment options
• Privacy protections
• The right to withdraw

Signing informed consent allows screening procedures to begin. It does not remove the
participant’s right to stop at any time.

Step 3: The Screening Visit

The screening visit confirms eligibility using objective information.

Depending on the protocol, screening may include:

• A physical examination
• A detailed medical history review
• Blood and urine testing
• An electrocardiogram
• Imaging
• Psychological or condition-specific assessments
• A review of current medications

Study-required screening procedures are generally provided at no cost to the volunteer.

Step 4: Enrollment or Screen Failure

If all inclusion requirements are met and no exclusion criteria apply, the volunteer may
be enrolled.

If one or more criteria are not met, the outcome is commonly called a screen failure.
Although the term may sound discouraging, it simply means the trial was not the right match.

Screen failure is common. Clinical trials often require a narrowly defined population,
and many interested volunteers do not qualify for the first study they consider.

What Happens If You Do Not Qualify?

Not qualifying for one study does not mean you will not qualify for another.

Every protocol defines its own participant population. A factor that excludes someone
from one trial may be acceptable—or even required—in another.

If you do not qualify, consider the following steps:

Ask Why

The research team may be able to explain which criterion was not met.

Sometimes the reason is temporary, such as a recent medication change, a laboratory value,
or recent participation in another study.

Ask About Other Studies

Research sites often conduct multiple trials and may have another study that is a better fit.

Join a Volunteer Registry

Many clinical research sites maintain volunteer databases and contact interested individuals
when a potentially suitable study becomes available.

You can contact AIM Trials to learn about current studies and future research opportunities.

Keep Your Information Current

Eligibility reflects your health information at a particular point in time.

New trials open regularly, and changes in diagnosis, treatment history, medications, or
overall health may affect future eligibility.

Share Relevant Findings With Your Doctor

Screening assessments may occasionally identify information that a volunteer did not
previously know. When appropriate, the research team may recommend discussing the
information with the volunteer’s regular healthcare provider.

Common Myths About Eligibility Criteria

Myth: “If I Am Excluded, It Means I Am Too Sick to Help”

Exclusion often has little to do with a person’s overall health.

People may be excluded because of age, medication use, timing, laboratory results, or
logistical requirements. Eligibility measures fit for one protocol, not personal worth.

Myth: “The Research Site Can Make an Exception”

Legitimate research sites cannot simply waive protocol requirements.

Eligibility criteria are written into the protocol, reviewed by an IRB, and applied across
participating locations.

Myth: “Eligibility Criteria Are Designed to Keep People Out”

Criteria are intended to identify the population in whom participation is considered safe
and the study question can be answered reliably.

Regulators and researchers continue to examine whether some criteria can be safely broadened.

Myth: “Once I Pass Screening, I Am Committed”

Participation remains voluntary throughout the study.

Passing screening and enrolling does not remove a participant’s right to withdraw.

Myth: “Clinical Trials Are Only for People Who Have Run Out of Options”

Clinical trials enroll many types of volunteers.

• Newly diagnosed patients
• People managing long-term conditions
• People who have not responded to previous treatments
• People who are currently stable
• Healthy volunteers

How Eligibility Criteria Are Changing

Eligibility criteria are not static. In recent years, many sponsors and regulators have
worked toward broader and more representative clinical trial enrollment.

Historically, some protocols used restrictive criteria carried forward from earlier studies
without a new scientific justification.

This sometimes produced trial populations that were younger, healthier, and less diverse
than the real-world patients who would eventually receive the treatment.

Modern guidance encourages sponsors to:

• Broaden criteria when safety allows
• Review each exclusion criterion for scientific necessity
• Include participants with controlled chronic conditions when appropriate
• Widen age ranges when justified
• Improve representation across populations
• Design studies that better reflect real-world patients

Practical trial changes may also reduce barriers for volunteers.

These may include:

• Telehealth appointments
• Local laboratory testing
• Home nursing visits
• Electronic questionnaires
• Remote symptom monitoring
• More flexible scheduling

For volunteers, the takeaway is encouraging: a person who did not qualify for a study
several years ago may find that newer protocols evaluate the same situation differently.

How to Find Out If You Are Eligible for a Clinical Trial

You do not need to interpret a complex protocol on your own.

1. Contact a Research Site Near You

A local research center can review your basic information against currently enrolling
studies.

AIM Trials is located in Plano, Texas, and serves volunteers throughout Dallas, Plano,
Frisco, Richardson, Garland, Irving, and the greater Dallas–Fort Worth area.

2. Search ClinicalTrials.gov

The federal clinical trial registry includes studies from across the United States and
around the world.

Each listing includes eligibility information, although the terminology may be technical.
A research coordinator may be able to help explain how the criteria apply.

3. Ask Your Healthcare Provider

Your regular doctor may know about studies related to your condition and can help you
consider whether research participation is appropriate.

4. Prepare Your Health Information

Having accurate information available can make pre-screening more efficient.

Helpful information includes:

• A current medication list
• Approximate diagnosis dates
• Past treatment names
• Treatment doses and durations
• Known allergies
• Relevant medical conditions
• Recent clinical trial participation

5. Ask Questions

Questions you may want to ask include:

• Why does the study have this eligibility requirement?
• What does screening involve?
• How many study visits are required?
• What happens if I do not qualify?
• Is there any cost to participate?
• Is compensation available for time or travel?
• Can I withdraw after enrolling?

Frequently Asked Questions About Eligibility Criteria